Agenda at a glance

Targeting Phage Therapy 2018 – Program2

 

Don’t forget to submit an abstract if you would like to present your research and innovations during Phage & Antibiotic Resistance Congress.

Day  1 – May 17, 2018
  07h30 – 9h00 Registration & Welcoming
  08h55 Welcome Address

  09h00 – 09h20

General Introduction:
How to overcome and combat antibiotic resistance in 2018?

  09h20 – 10h40

Session 1: Phage Therapy 2018: recent advances & challenges (part 1)

Fighting multi-drug resistant Klebsiella pneumoniae by using lytic phages 
Marco Maria D’Andrea, Università di Siena, Italy

Control of catheter associated biofilms through efflux inhibition
Brian Jones, Queen Victoria Hospital NHS Foundation Trust, United Kingdom

Impact of virulent bacteriophages on vibrio cholerae infection and their use in preventing cholera
Minmin Yen,
Tufts University, USA

  10h40 – 11h20 Coffee Break & Poster Session
  11h20 – 12h40

 Session 1: Phage Therapy 2018: recent advances & challenges (part 2)

Phage therapy of infectious biofilms
Joana Azeredo, 
CEB – University of Minho, Portugal

Lytic bacteriophages in the treatment of biofilm-forming bacteria involved in prosthetic joint infections
Mariagrazia Di Luca, 
Charité – Universitätsmedizin Berlin Hospital, Germany

Microencapsulation of purified bacteriophages for targeted therapeutic applications
Danish Malik, Loughborough University, United Kingdom

Direct phenotypic screening to identify new antimicrobial agents
Mark Sutton, 
National Infections Service, Public Health England, United Kingdom


  12h40 – 14h00 Lunch Break & Poster Session

  14h00 – 15h30

 Session 1: Phage Therapy 2018: recent advances & challenges (part 3)

Development of infection-responsive surface coatings for bacteriophage delivery in the catheterised urinary tract
Jonathan Nzakizwanayo, Queen Victoria Hospital NHS Foundation Trust, United Kingdom

Development and use of personalized bacteriophage-based therapeutic cocktails to treat a patient with a disseminated resistant Acinetobacter baumannii infection
Robert T. Scholley,
University of California, USA

  14h40 – 15h30

Call for Short Oral Presentations

Among presentations already accepted:

Selection and characterisation of phages able to degrade biofilm produced by clinical isolates of E.faecalis
Pasquale Marmo,
University of Roma Tor Vergata, Italy

State-of-the-art of modeling in vivo dynamics of naturally-occurring phages and in vivo dynamics of therapeutic phages
Victoriya Volkova,
Kansas State University, USA

Bacteriophage therapy and urinary tract infections
Tamara Perepanova, S.R. Institute of Urology  and Interventional Radiology, Russia

Safe & active sustained release of phages in gastro-intestinal tract
Farzaneh Moghtader, Hacettepe University, Turkey

Mycobacteriophage based platforms to discover drug targets for mycobacteria
Sujoy Das Gupta, Bose Institute, India

Efficient in vivo phage therapy via immunological cloaking
Yoon Sung Nam, Korea Advanced Institute of Science & Technology, Korea

Click here to access the corresponding tracks >>

  15h30 – 16h15 Coffee Break & Poster Session

  16h15 – 17h00 Call for Short Oral Presentations

Click here to access the corresponding tracks >>

  18h30  End of the first day
  20h00

Targeting Phage & Antibiotic Resistance Dinner

To participate, please register online before May 2nd.

Day  2 – May 18, 2018
  08h55 Opening of the second day
  09h00 – 10h30

Session 2: Innovations against antibiotic resistance (part 1)

Focus on the new generation of antibiotics

Focus on the strategic role of microbiota to overcome antibiotic resistance

Antimicrobial discovery from extreme halophiles
Brendan Gilmore, Queen’s University Belfast, United Kingdom

General overview on the transmission of multidrug-resistant Mycobacterium tuberculosis
Qian Gao,
 Fudan University, China

Microarray patches for prevention and treatment of infectious diseases and their potential for reducing antibiotic resistance
Ryan Donnelly, Queen’s University Belfast, United Kingdom

  10h30 – 11h00 Coffee Break & Poster Session
  11h00 – 12h00  Session 2: Innovations against antibiotic resistance (part 2)
 12h00 – 12h45

Reincarnation of a staphylococcal pathogenicity island as an antibacterial drone
Richard Novick, New York University, USA

Call for Short Oral Presentations

Inhibition of Shikimate kinase from M. Tuberculosis and H. Pylori for antibiotic discovery
Concepción González-Bello, Universidade de Santiago de Compostela, Spain

Click here to access the corresponding tracks >>


  12h45 – 14h00 Lunch Break & Poster Session

  14h00 – 15h30

Session 3: Special Session for Industrials: Innovations & Perspectives

This session is dedicated only to industrials, pharma companies, biotech and start-ups, to showcase their innovations. 

Phage-based antimicrobials: novel approaches for managing drug-resistant bacteria
Alexander Sulakvelidze, Intralytix, USA

Novel phage based therapeutics to address antibiotic resistance
Naomi Zak, Biomx, United Kingdom

Call for Short Oral Presentations

Click here to access the corresponding tracks >>

  15h30 – 16h00 Coffee Break & Poster Session
  16h00 – 17h00 Call for Short Oral Presentations

Click here to access the corresponding tracks >>

  17h00 – 17h45 Round Table Discussion & Concluding Remarks 
 17h45 – 18h00

Targeting Phage & Antibiotic Resistance Awards

  18h00 End of Targeting Phage & Antibiotic Resistance 2018